Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Agilent Technologies, Inc. A

Healthcare — Diagnostics & Research
S&P 500 Member Dividend Champion (3y)
Indexes indicate stock being part of an index ,
Growth Flags show if company had growth for consecutive years

Agilent Technologies, Inc. (A) Business Profile

Company Overview

Agilent Technologies, Inc. (Agilent) is a global leader in life sciences, diagnostics, and applied chemical markets. The company was founded in 1999 as a spin-off from Hewlett-Packard Company, inheriting HP’s legacy of innovation and excellence in measurement technologies. Headquartered in Santa Clara, California, Agilent operates in over 100 countries worldwide. The company is led by Michael R. McMullen, who has served as President and CEO since 2015. Under his leadership, Agilent has focused on expanding its portfolio of cutting-edge technologies and strengthening its position in the global market.

Agilent’s mission is to improve the quality of life by providing innovative solutions that enable customers to achieve scientific breakthroughs. The company serves a diverse range of industries, including pharmaceuticals, biotechnology, environmental testing, food safety, and academic research.

Core Business Segments

Agilent operates through three primary business segments, each offering a wide range of products and services:

1. Life Sciences and Applied Markets (LSAG)

This segment focuses on providing analytical instruments, software, and consumables for life sciences research and applied chemical markets. Key products and services include:

  • Chromatography Systems: Gas chromatography (GC) and liquid chromatography (LC) systems for separating and analyzing complex mixtures.
  • Mass Spectrometry: High-performance mass spectrometers for identifying and quantifying chemical compounds.
  • Spectroscopy Instruments: Atomic absorption, molecular spectroscopy, and inductively coupled plasma (ICP) systems for elemental and molecular analysis.
  • Lab Automation: Robotic systems and software for automating laboratory workflows.

2. Diagnostics and Genomics (DGG)

This segment provides tools and solutions for clinical diagnostics, genomics, and molecular biology. Key offerings include:

  • Pathology Solutions: Immunohistochemistry (IHC) and in situ hybridization (ISH) products for cancer diagnostics.
  • Genomics Tools: Microarrays, next-generation sequencing (NGS) solutions, and PCR systems for genetic analysis.
  • Clinical Diagnostics: Instruments and reagents for disease detection and monitoring.

3. Agilent CrossLab Group (ACG)

The CrossLab segment focuses on providing services, consumables, and software to enhance laboratory productivity. Key offerings include:

  • Lab Services: Instrument installation, maintenance, and repair services.
  • Consumables: Columns, sample preparation products, and other laboratory essentials.
  • Software Solutions: Data analysis and laboratory information management systems (LIMS).

Business Model

Agilent’s business model is centered on integrating high-quality products with value-added services to create comprehensive solutions for its customers. The company generates revenue through the sale of instruments, consumables, and software, as well as recurring revenue from service contracts and subscriptions. Agilent’s approach emphasizes:

  • Customer-Centric Innovation: Developing products and services tailored to the specific needs of its customers.
  • Global Reach: Leveraging its extensive global network to serve customers in diverse industries and regions.
  • Sustainability: Incorporating environmentally friendly practices into its operations and product designs.

Strategic Direction

Agilent is committed to driving growth through innovation, sustainability, and customer focus. Key strategic initiatives include:

  • Expanding Service Offerings: Increasing the range of CrossLab services to enhance customer loyalty and generate recurring revenue.
  • Sustainability Goals: Reducing the environmental impact of its operations and products, with a focus on energy efficiency and waste reduction.
  • New Product Development: Investing in R&D to develop advanced technologies in areas such as genomics, proteomics, and precision medicine.
  • Geographic Expansion: Strengthening its presence in emerging markets, particularly in Asia-Pacific and Latin America.

Competitive Landscape

Agilent operates in highly competitive markets, facing competition from both established players and emerging companies. Key competitors include:

  • Thermo Fisher Scientific: A leading provider of analytical instruments, reagents, and services.
  • Danaher Corporation: Known for its portfolio of life sciences and diagnostics tools.
  • Waters Corporation: Specializes in chromatography and mass spectrometry solutions.
  • PerkinElmer: Offers a wide range of analytical and diagnostic instruments.
  • Bruker Corporation: Focuses on advanced analytical and diagnostic technologies.

Agilent differentiates itself through its strong brand reputation, innovative product portfolio, and customer-centric approach.

Risk Factors

Agilent faces several risks that could impact its business operations and financial performance:

  • Market Dependence: Reliance on specific industries, such as pharmaceuticals and biotechnology, makes the company vulnerable to market fluctuations.
  • Supply Chain Disruptions: Global supply chain challenges, including shortages of raw materials and components, could affect production and delivery timelines.
  • Regulatory Compliance: Operating in highly regulated industries requires adherence to stringent standards, which can increase costs and complexity.
  • Currency Fluctuations: As a global company, Agilent is exposed to risks associated with foreign exchange rate fluctuations.

Recent Developments

Agilent has made significant strides in recent years, including:

  • New Product Launches: Introduction of advanced mass spectrometry systems and genomics tools to meet evolving customer needs.
  • Sustainability Initiatives: Implementation of energy-efficient manufacturing processes and reduction of greenhouse gas emissions.
  • Strategic Acquisitions: Acquisition of companies specializing in genomics and diagnostics to expand its product portfolio.
  • COVID-19 Response: Development of diagnostic solutions and support for vaccine research during the pandemic.

Investment Considerations

Investors considering Agilent should weigh the following factors:

Strengths:

  • Strong brand reputation and market leadership.
  • Diversified product portfolio and revenue streams.
  • Commitment to innovation and sustainability.
  • Robust financial performance and growth potential.

Risks:

  • Exposure to market fluctuations and regulatory challenges.
  • Dependence on key industries and geographic regions.
  • Potential impact of supply chain disruptions and currency fluctuations.

Conclusion

Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, with a strong focus on innovation, sustainability, and customer satisfaction. The company’s diversified product portfolio, strategic initiatives, and commitment to excellence position it for continued growth in the years ahead. While challenges such as market dependence and supply chain disruptions remain, Agilent’s strengths and strategic direction make it a compelling choice for investors and customers alike.

© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us